Chief Executive Officer Hyunjin Jung, M.D.
  • M.D., Seoul National University
  • Founder and CEO, Innocell
    (Currently Green Cross Cell)
  • CEO, Biomedical Holdings
  • CEO, STSciences, Inc.
  • Development of
    Immune Cell Therapy
    (Currently Marketed)
  • Phase III Clinical Trials on
    Liver Cancer
  • Phase III Clinical Trials on
    Brain Tumor
Chief Executive Officer / Chief Science Officer Stephen S. Yoo, Ph.D.
  • B.S., Biology, Yonsei University
  • Ph.D., Biochemistry/Biophysics, Texas A&M University
  • Postdoctoral Researcher, Chemistry/Biochemistry,
    University of Colorado at Boulder
  • Instructor, Institute of Molecular Medicine & Genetics,
    Medical College of Georgia
  • Faculty, Radiation Medicine, Georgetown University Medical School
  • Branch Chief, Molecular Radiation Therapeutics Branch, NCI/NIH
Chief Financial Officer Junyong Park, MBA
  • MBA, Finance, Korea University
  • Executive Director, Unibest Capital (VC)
  • Executive Director, Pyxisnet
  • Executive Director, OncoBioscience
  • Executive Director, Si-gong Law Firm
VP, Legal & Alliance Hoon Choi, J.D., Ph.D.
  • B.S., Biochemistry, Yonsei University
  • Ph.D., Biochemistry, University of Houston
  • J.D., Georgetown University Law Center
  • Associate Attorney, Pennie & Edmonds
  • Partner, Jones Day